Median OS in the PS subgroup was longer than for the EMD subgroup or reference patients but did not reach statistical significance (59.4 months (95% CI: 48.1–73.3) vs. 43.8 months (95% CI: 34.9–61.5) vs. 55.0 months (95% CI: 51.6–58.9), p = 0.229).
← all excerpts
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
1
0.2290
0.2290